Stay updated with breaking news from Nasdaq Eldn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 28,700 shares, an increase of 64.9% from the March 15th total of 17,400 shares. Based on an average daily trading volume, of 25,700 shares, […]
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating)’s stock price traded down 4.3% during mid-day trading on Friday . The company traded as low as $2.40 and last traded at $2.44. 11,463 shares were traded during trading, a decline of 55% from the average session volume of 25,521 shares. The stock had previously closed at $2.55. […]
Eledon to Incorporate the iBox Scoring System in Future Kidney Transplant Trials...
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 39,900 shares, an increase of 250.0% from the May 15th total of 11,400 shares. Currently, 0.3% of the company’s shares are sold short. Based […]
Eledon Pharmaceuticals (NASDAQ:ELDN – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Eledon Pharmaceuticals Inc. is a clinical stage biotechnology company. It develop treatments for an organ or cell-based transplant, and for people […]